Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

822817

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the rate of early diagnosis of cancer.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122500
answer	answer is ministerial correction date of answer 22/01/2018 answer text <p>To raise awareness of cancer symptoms and encourage people with symptoms to go to their doctor without delay, we have run 13 national Be Clear on Cancer awareness campaigns since 2010/11. A national respiratory symptoms campaign ran from April to the end of August 2017, focusing on the symptoms of a persistent cough and inappropriate breathlessness. The campaign covered lung cancer along with other conditions such as heart disease and lung disease.</p><p> </p><p>Public Health England has developed a pilot on the abdominal symptoms which can be a sign of a number of cancers. This ran in the East and West Midlands in February and March 2017. Working in partnership with Be Clear on Cancer, Cancer Research UK has piloted a campaign in the North West on increasing uptake of bowel cancer screening in January and March 2017.</p><p> </p><p>Bowel scope screening has been rolled out to 98% of centres in England and over 300,000 55 year-olds have been screened so far.</p><p> </p><p>As recommended by the UK National Screening Committee and the independent Cancer Taskforce, we are modernising our world renowned cancer screening programmes by introducing Faecal Immunochemical Testing into the NHS Bowel Cancer Screening Programme during 2018/19 and human papillomavirus as the primary test in the NHS Cervical Screening Programme by December 2019.</p><p> </p><p>NHS England’s Accelerate, Co-ordinate, Evaluate (ACE) programme is testing innovative ways of diagnosing cancer earlier, with ACE Wave 2 piloting multi-disciplinary diagnostic centres for patients with vague or non-specific symptoms. The pilots are taking place in London, Greater Manchester, Leeds, Bristol, Oxfordshire and Airedale, Wharfedale and Craven (Yorkshire).</p><p> </p><p>The National Institute for Health Care and Excellence updated referral guidelines for suspected cancer published in June 2015 could save about 5,000 lives a year with general practitioners urged to think of cancer sooner and lower the referral threshold for tests.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/01/2018 11:49:46 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

822819

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Doctors: Stress
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce workload-related strain on doctors in hospitals.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122502
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>It is in the first instance for employers to ensure that the workloads and working patterns of all staff are appropriate.</p><p> </p><p>The Department is supporting the National Health Service in reducing workload related strain on all staff including doctors in hospitals through its mandate with NHS England which has a “Commissioning for Quality and Innovation” (CQUIN) incentive programme<sup>1</sup> to improve staff health and wellbeing, and publishes the annual NHS Staff Survey.</p><p> </p><p>NHS England’s CQUIN programme should encourage trusts to, where appropriate, introduce new services for employees to give them the support they need including quicker access to mental health and musculoskeletal services.</p><p> </p><p>The NHS Staff Survey<sup>2</sup> asks staff a range of questions about their health and wellbeing which helps trusts benchmark against their peers to help inform local improvement plans.</p><p> </p><p>The Department also commissions NHS Employers<sup>3</sup>, who are working with NHS England, NHS Improvement and Public Health England to help the Service tackle the causes of workload related strain including reducing the likelihood and impact of resultant illnesses through advice, guidance and good practice as well as tools and resources for trusts to use.</p><p> </p><p>National terms and conditions for hospital doctors include provisions on managing work: through job plans for consultants, associate specialists and specialty doctors; and work schedules for doctors and dentists in training. There are limits on working hours in legislation; there are stronger contractual limits in the 2016 contract for doctors and dentists in training and all trusts were required to review and, where needed, redesign rotas to ensure compliance with those limits. There are strong safeguards in place for doctors and dentists in training through a system of exception reporting, with oversight by Guardians of Safe Working Hours and Directors of Medical Education reporting to trust boards. Trusts must provide annual reports on rota gaps, and plans for addressing them, to external bodies including regulatory bodies.</p><p> </p><p>Notes:</p><p> </p><p><sup>1</sup><a href="https://www.england.nhs.uk/publication/nhs-staff-health-wellbeing-commissioning-for-quality-and-innovation-cquin-2017-19-indicator-1-implementation-support/" target="_blank">https://www.england.nhs.uk/publication/nhs-staff-health-wellbeing-commissioning-for-quality-and-innovation-cquin-2017-19-indicator-1-implementation-support/</a></p><p> </p><p><sup>2</sup><a href="http://www.nhsstaffsurveys.com/Page/1006/Latest-Results/2016-Results/" target="_blank">http://www.nhsstaffsurveys.com/Page/1006/Latest-Results/2016-Results/</a></p><p> </p><p><sup>3</sup><a href="http://www.nhsemployers.org/your-workforce/retain-and-improve/staff-experience/health-work-and-wellbeing" target="_blank">http://www.nhsemployers.org/your-workforce/retain-and-improve/staff-experience/health-work-and-wellbeing</a></p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 23/01/2018 17:18:32 answering member 4095 label Biography information for Steve Barclay
tabling member	4131 label Biography information for Jim Shannon

822826

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to a Hepatitis C elimination plan in order to meet the WHO target of eliminating the disease as a public health threat by 2030; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122509
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>The Government is committed to meeting the World Health Organization (WHO) target of eliminating hepatitis C by 2030 but there are no plans at this time to publish a strategy to eliminate hepatitis C. A variety of initiatives are underway in England to improve awareness and case finding, re-engagement and linkage to care, especially in drug services, primary care, prisons and accident and emergency centres. In addition, NHS England is funding access to new hepatitis C treatments in accordance with guidance from the National Institute for Health and Care Excellence (NICE).</p><p> </p><p>A summary of progress towards achieving the WHO elimination goal was published in 2017 in Public Health England’s report, ‘Hepatitis C in the UK’, is available at:</p><p> </p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/632465/HCV_in_the_uk_report_2017.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/632465/HCV_in_the_uk_report_2017.pdf</a></p><p> </p><p>This showed that the United Kingdom is on target to meet the WHO interim goal of reducing hepatitis C mortality by 10% by 2020. Better access to improved treatment has led to the first fall in deaths from severe hepatitis C related liver disease in decade.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/01/2018 17:23:53 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

822827

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hepatitis: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to discuss with the pharmaceutical industry steps to ensure that all patients who suffer from Hepatitis C have access to the full range of available medicines.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122510
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>Currently, patients with chronic hepatitis C have access to all National Institute of Health and Care Excellence (NICE) approved hepatitis C treatments where clinically appropriate in line with current NICE guidance. Procurement of hepatitis C drugs is already undertaken every six months and this process involves discussion with industry regarding improving the cost to the National Health Service of these treatments. NHS England is continuing its work with industry on the prospects for a different approach to procurement which would further improve cost of these treatments.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/01/2018 14:11:09 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

822828

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the Hepatitis C treatment rates were for each Operational Delivery Network in 2016-17.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122511
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>The information is not available in the format requested. Each Operational Delivery Network (ODN) was allocated a share of the national 10,000 treatment run rate for 2016-17 based on estimated need. Allocations were varied in the course of the year so it is therefore not possible to provide treatment rates. The table below provides information on the number of treatments completed by each ODN in 2016-17.</p><p><strong> </strong></p><table><tbody><tr><td><p>Network</p></td><td><p>Actual</p></td></tr><tr><td><p>Barts</p></td><td><p>494</p></td></tr><tr><td><p>Birmingham</p></td><td><p>748</p></td></tr><tr><td><p>Bristol and Severn Hep C ODN</p></td><td><p>326</p></td></tr><tr><td><p>Cheshire &amp; Merseyside</p></td><td><p>347</p></td></tr><tr><td><p>Eastern Hepatitis Network</p></td><td><p>586</p></td></tr><tr><td><p>Greater Manchester &amp; Eastern Cheshire</p></td><td><p>687</p></td></tr><tr><td><p>Humberside and North Yorkshire</p></td><td><p>377</p></td></tr><tr><td><p>Kent Network via Kings</p></td><td><p>154</p></td></tr><tr><td><p>Lancashire &amp; South Cumbria</p></td><td><p>330</p></td></tr><tr><td><p>Leicester</p></td><td><p>255</p></td></tr><tr><td><p>North Central London Viral Hepatitis Network</p></td><td><p>730</p></td></tr><tr><td><p>North East &amp; Cumbria</p></td><td><p>395</p></td></tr><tr><td><p>Nottingham</p></td><td><p>383</p></td></tr><tr><td><p>South Thames Hepatitis Network</p></td><td><p>870</p></td></tr><tr><td><p>South Yorkshire</p></td><td><p>340</p></td></tr><tr><td><p>Surrey Hepatitis Services</p></td><td><p>154</p></td></tr><tr><td><p>Sussex Hepatology Network</p></td><td><p>241</p></td></tr><tr><td><p>SW Peninsula Hepatitis C ODN</p></td><td><p>328</p></td></tr><tr><td><p>Thames Valley Hep C ODN</p></td><td><p>347</p></td></tr><tr><td><p>Wessex Hep C ODN</p></td><td><p>341</p></td></tr><tr><td><p>West London</p></td><td><p>562</p></td></tr><tr><td><p>West Yorkshire</p></td><td><p>445</p></td></tr><tr><td><p>Total</p></td><td><p>9,440</p></td></tr></tbody></table><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/01/2018 17:27:31 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

822829

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how his Department plans to increase the number of Hepatitis C patients who are diagnosed and treated.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122512
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>Initiatives to increase the number of patients diagnosed with hepatitis C infection (HCV) include raising public and professional awareness, improving case finding, and re-engagement and linkage to care - especially in drug services, primary care, prisons and accident and emergency centres.</p><p> </p><p>NHS England is rolling out an Opt-Out Blood Borne Viruses testing programme; the key aim is to improve uptake rates for hepatitis C testing across the adult prison estate by end of 2017-18.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guidelines are available to help raise awareness of, and testing for, hepatitis C infection in people at increased risk of infection. The guidelines can be viewed at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ph43" target="_blank">https://www.nice.org.uk/guidance/ph43</a></p><p> </p><p>A variety of interventions for improved case-finding have been implemented, including home sampling for hepatitis C and improving engagement of diagnosed individuals in primary care (including migrants and people who have ever injected drugs). In addition the feasibility of opt-out testing in accident and emergency services is being explored.</p><p> </p><p>These interventions include non-invasive testing of oral fluid, dried blood spot testing to facilitate uptake.</p><p> </p><p>Mobile find and test services and a scheme offering testing for HCV in people who inject drugs who use pharmacy needle exchange services are being piloted.</p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122513 question first answered 23/01/2018 17:24:57 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

822830

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to (a) increase the extent and frequency of testing and (b) improve treatment for Hepatitis C for people who inject drugs .
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122513
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>Initiatives to increase the number of patients diagnosed with hepatitis C infection (HCV) include raising public and professional awareness, improving case finding, and re-engagement and linkage to care - especially in drug services, primary care, prisons and accident and emergency centres.</p><p> </p><p>NHS England is rolling out an Opt-Out Blood Borne Viruses testing programme; the key aim is to improve uptake rates for hepatitis C testing across the adult prison estate by end of 2017-18.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guidelines are available to help raise awareness of, and testing for, hepatitis C infection in people at increased risk of infection. The guidelines can be viewed at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ph43" target="_blank">https://www.nice.org.uk/guidance/ph43</a></p><p> </p><p>A variety of interventions for improved case-finding have been implemented, including home sampling for hepatitis C and improving engagement of diagnosed individuals in primary care (including migrants and people who have ever injected drugs). In addition the feasibility of opt-out testing in accident and emergency services is being explored.</p><p> </p><p>These interventions include non-invasive testing of oral fluid, dried blood spot testing to facilitate uptake.</p><p> </p><p>Mobile find and test services and a scheme offering testing for HCV in people who inject drugs who use pharmacy needle exchange services are being piloted.</p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122512 question first answered 23/01/2018 17:24:57 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

822842

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of minimum unit pricing on alcohol-related hospital admissions.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	122525
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Public Health England published an evidence review on the public health impact of alcohol and the effectiveness of policies for reducing alcohol-related harm in December 2016. The review concluded that reducing the affordability of alcohol is the most effective way of reducing alcohol harm, including hospital admissions and deaths, and targeted pricing measures are particularly effective at reducing harm in those groups most at risk.</p><p> </p><p>The review also found that targeting price increases at the cheapest alcohol is very effective and cost-effective and is able to substantially reduce harm in heavy drinkers without affecting moderate drinkers or the price of alcohol sold in pubs and bars. Modelling studies by the University of Sheffield on the impact of minimum unit price was shown to have a positive impact in closing the health inequalities gap between those in the highest and those in the lowest socioeconomic groups. These studies are available at:</p><p> </p><p><a href="https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf" target="_blank">https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf</a></p><p> </p><p>Minimum unit pricing and its effects will continue to remain under review pending the impact of its implementation in Scotland.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 16:46:23 answering member 4067 label Biography information for Steve Brine
tabling member	4603 label Biography information for Preet Kaur Gill

822843

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of minimum unit pricing on the level of alcohol-related deaths.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	122526
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Public Health England published an evidence review on the public health impact of alcohol and the effectiveness of policies for reducing alcohol-related harm in December 2016. The review concluded that reducing the affordability of alcohol is the most effective way of reducing alcohol harm, including hospital admissions and deaths, and targeted pricing measures are particularly effective at reducing harm in those groups most at risk.</p><p> </p><p>The review also found that targeting price increases at the cheapest alcohol is very effective and cost-effective and is able to substantially reduce harm in heavy drinkers without affecting moderate drinkers or the price of alcohol sold in pubs and bars. Modelling studies by the University of Sheffield on the impact of minimum unit price was shown to have a positive impact in closing the health inequalities gap between those in the highest and those in the lowest socioeconomic groups. These studies are available at:</p><p> </p><p><a href="https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf" target="_blank">https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf</a></p><p> </p><p>Minimum unit pricing and its effects will continue to remain under review pending the impact of its implementation in Scotland.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 16:46:24 answering member 4067 label Biography information for Steve Brine
tabling member	4603 label Biography information for Preet Kaur Gill

822844

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of minimum unit pricing for alcoholic drinks on health inequalities.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	122527
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>Public Health England (PHE) published an evidence review on the public health impact of alcohol and the effectiveness of policies for reducing alcohol-related harm in December 2016. The review concluded that reducing the affordability of alcohol is the most effective way of reducing alcohol harm, and targeted pricing measures are particularly effective at reducing harm in those groups most at risk. Modelling studies by the University of Sheffield highlighted by PHE suggest that minimum unit price would have a positive impact in closing the health inequalities gap between those in the highest and those in the lowest socioeconomic groups. These studies are available at:</p><p> </p><p><a href="https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf" target="_blank">https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf</a></p><p> </p><p>Minimum unit pricing and its effects will continue to remain under review pending the impact of its implementation in Scotland.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/01/2018 14:09:19 answering member 4067 label Biography information for Steve Brine
tabling member	4603 label Biography information for Preet Kaur Gill